Health Crisis Spirals in Colombia as ERs and Maternity Wards Close
First maternity wards and neonatal units started shutting down.Now emergency rooms are closing their doors. Patients are waiting longer for urgent care. And families are struggling to pay for medicines that used to be provided for free.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
15 minutes ago
- Yahoo
Dr. Sagy Grinberg Healing Hands Scholarship for Healthcare Launches to Support Future Medical Leaders
New York, New York--(Newsfile Corp. - August 20, 2025) - The Dr. Sagy Grinberg Healing Hands Scholarship for Healthcare is now officially open for applications, offering a meaningful opportunity for undergraduate students in healthcare fields to share their inspiration and vision for the future of medicine. Designed to recognize passion, purpose, and potential in aspiring healthcare professionals, the scholarship aims to support students dedicated to making a measurable difference in the lives of others through compassionate care and clinical excellence. Dr. Sagy Grinberg To view an enhanced version of this graphic, please visit: Dr. Sagy Grinberg, a board-certified physician in internal medicine and infectious diseases, spearheads this initiative with the goal of investing in the next generation of healthcare leaders. As the lead physician of his private practice, Dr. Sagy Grinberg brings decades of experience in hospital medicine, outpatient care, and research. His scholarship reflects his continued commitment to nurturing individuals who share his vision of patient-centered, evidence-based care. Open to undergraduate students enrolled at accredited U.S. institutions, the Dr. Sagy Grinberg Healing Hands Scholarship for Healthcare invites applicants from all healthcare-related fields, including medicine, nursing, public health, biomedical sciences, and other allied health programs. This national scholarship is not limited to any specific region or state, making it accessible to all eligible students pursuing healthcare degrees across the United States. To apply, students must submit an original essay of 750 to 1,000 words addressing the following prompt: "What inspires you to pursue a career in healthcare, and how do you plan to make a meaningful impact in the lives of others through your future work?" Applications are being accepted now through January 15, 2026, and the selected recipient will be announced on February 15, 2026. Dr. Sagy Grinberg strongly believes in the power of storytelling to uncover authentic commitment, and the essay component plays a key role in evaluating each applicant's unique voice and mission. The scholarship is a personal endeavor by Dr. Sagy Grinberg to give back to a field that has shaped his life and career. His work has consistently reflected a dedication to advancing healthcare through both compassionate treatment and scientific rigor. Through the Dr. Sagy Grinberg Healing Hands Scholarship, he hopes to encourage students who exhibit that same sense of purpose and responsibility. Dr. Sagy Grinberg has long advocated for holistic development among future medical professionals. He understands that academic training is only one facet of a successful healthcare career-the values of empathy, innovation, and community service are equally vital. By launching this scholarship, Dr. Sagy Grinberg affirms his belief that true impact in healthcare comes not only from knowledge, but from human connection and integrity. Students interested in applying or learning more about the scholarship requirements can visit the official website at This initiative reflects Dr. Sagy Grinberg's enduring investment in mentoring and inspiring future practitioners. Through this scholarship, Dr. Sagy Grinberg continues his mission of building a future where healthcare is led by professionals who prioritize service, empathy, and lasting impact. Contact Information:Spokesperson: Dr. Sagy GrinbergOrganization: Dr. Sagy Grinberg Healing Hands Scholarship for HealthcareWebsite: apply@ To view the source version of this press release, please visit Error while retrieving data Sign in to access your portfolio Error while retrieving data Error while retrieving data Error while retrieving data Error while retrieving data
Yahoo
2 hours ago
- Yahoo
Global Healthcare Gets a 6G Boost: Market to Grow at 77.9% CAGR Through 2040
"This report explores how 6G is poised to reshape global healthcare through innovations in remote patient monitoring, AR/VR diagnostics, robotic surgeries, and smart hospital infrastructure, powered by ultra-low latency, AI integration, and massive device connectivity." BOSTON, Aug. 20, 2025 /PRNewswire/ -- According to the latest study from BCC Research, the "6G in Healthcare: Global Market" is projected to reach $194 billion by the end of 2040 with a CAGR of 77.9% from 2031 to 2040. The report analyzes the global 6G market in healthcare, exploring trends, challenges, and growth drivers. It segments the market by component, application, connectivity, end user, and region, covering the major areas of North America, Europe, Asia-Pacific, the Middle East and Africa, and South America. Additionally, it evaluates the competitive landscape by ranking leading companies and profiling major players. This report is especially relevant now as the global momentum toward digital healthcare transformation continues to grow, and research into 6G technology rapidly advances. It provides timely insights into how 6G is poised to revolutionize healthcare by enhancing delivery, boosting efficiency, and driving innovation. For early adopters and stakeholders, understanding these developments is crucial to staying ahead in a highly competitive and evolving landscape. The factors driving the market's growth include: Rising Demand for Enhanced Healthcare Services and Efficiency: Healthcare systems are under pressure to deliver faster, more personalized, and cost-effective care. 6G can support this by enabling real-time diagnostics, AI-powered decision-making, and seamless telemedicine experiences, ultimately improving service quality and operational efficiency. Growing Adoption of IoT and Connected Devices in Healthcare: The increasing use of wearables, smart medical equipment, and remote monitoring tools is transforming healthcare. 6G will enhance these technologies by offering faster data transmission, better connectivity, and improved energy efficiency, creating a smarter and more responsive healthcare ecosystem. Need for Ultra-Reliable and Low-Latency Communication for Critical Applications: In life-critical scenarios like remote surgeries or emergency response, reliability and speed are essential. 6G's ultra-low latency and high reliability ensure uninterrupted, secure communication, making it ideal for mission-critical healthcare applications. Request a sample copy of the global market trends for 6G in healthcare report. Report Synopsis Report Metric Details Base year considered 2030 Forecast period considered 2031-2040 Base year market size $664.2 million Market size forecast $194.0 billion Growth rate CAGR of 77.9% from 2031 to 2040 Segments covered Component, Application, Connectivity Type, End User, and Region Regions covered North America, Europe, Asia-Pacific, South America, and the Middle East and Africa (MEA) Countries covered U.S., Canada, Mexico, Brazil, Argentina, Japan, China, India, South Korea, Australia, Rest of Asia-Pacific, Germany, U.K., France, Italy, Spain, Rest of Europe, the Middle East, and Africa Market drivers • Rising demand for enhanced healthcare services and efficiency. • Growing adoption of IoT and connected devices in healthcare. • Need for ultra-reliable and low-latency communication for critical applications. Interesting facts: 6G technology is expected to be 100 times faster than 5G, enabling real-time remote surgeries, seamless medical data transmission, and continuous biometric streaming via wearables for predictive healthcare analytics. It will also support digital twins, the virtual patient models that allow doctors to simulate treatments before applying them in real life. The integration of AI and 6G could dramatically reduce emergency response times through intelligent, connected systems. South Korea and China are among the countries already investing in national initiatives to lead 6G healthcare innovations by 2030. The report addresses the following questions: 1. What are the projected size and growth rate of the market? The global market for 6G in healthcare is projected to reach $194 billion by the end of 2040, with a CAGR of 77.9%. 2. Which factors are driving the growth of the market? The growth of 6G in the healthcare market is driven by increasing demand for real-time patient monitoring and data-intensive applications. Advances in AI and IoMT are enhancing diagnostic precision and care delivery through ultra-fast connectivity. The rising adoption of telehealth and remote surgeries requires the low latency and high reliability that 6G offers. Growing investments in smart hospitals and digital infrastructure further propel the market expansion for 6G. 3. Which market segments are covered in the report? The market in this report is segmented by component, application, connectivity, and end user. 4. Which component segment will be dominant through 2040? The hardware segment will dominate the market for 6G in healthcare. 5. Which region has the highest market share? The North America market for 6G in healthcare was valued at $201.3 million in 2030 and is projected to reach $52.6 billion in 2040, at a CAGR of 76.0% during the forecast period. Market leaders include: APPLE AT&T CISCO SYSTEMS HUAWEI TECHNOLOGIES CO. LTD. INTEL MICROSOFT NOKIA QUALCOMM TECHNOLOGIES INC. SAMSUNG SIEMENS HEALTHINEERS AG Purchase a copy of the report direct from BCC Research. For further information on any of these reports or to make a purchase, contact info@ About BCC Research BCC Research market research reports provide objective, unbiased measurement and assessment of market opportunities. Our experienced industry analysts' goal is to help you make informed business decisions free of noise and hype. Contact UsCorporate HQ: 50 Milk St., Ste. 16, Boston, MA 02109, USAEmail: info@ +1 781-489-7301 For media inquiries, email press@ or visit our media page for access to our market research library. Any data and analysis extracted from this press release must be accompanied by a statement identifying BCC Research LLC as the source and publisher. Logo: View original content to download multimedia: SOURCE BCC Research LLC Sign in to access your portfolio
Forbes
2 hours ago
- Forbes
What Is Your Health Record Worth? The Unseen Economics Behind Your Medical Data
Two thousand years ago, physicians in Egypt documented their patients' symptoms and treatments on papyrus scrolls. These early medical records served a simple, localized purpose: they supported direct care, were referenced in case discussions, and played a role in medical education. For most of human history, medical documentation was a tool for the physician, with little utility beyond the immediate circle of care. But in the modern era, as records have gone digital, they have transformed into something else entirely: a commodity. Today, medical records are exchanged, aggregated, analyzed, and monetized at a scale unimaginable in the paper era. Governments, researchers, and corporations alike are tapping into their value. Yet, for all the headlines about billion-dollar data deals and the promise of AI-driven breakthroughs, the average American remains largely unaware of what their medical data is worth—or how little control they have over it. In fact, the reality of the health data economy may surprise many. While one survey suggests that 70% of Americans would only be willing to share their records for more than $1,000, the actual price those records fetch is often far lower. For instance, despite claims that hackers can sell health data for $250 per record, consider last year's Change Healthcare hacking episode. A security breach compromised the data of over 190 million Americans at the company, which is a UnitedHealth Group subsidiary. UnitedHealth Group reportedly paid the hackers $22 million in ransom—an implicit valuation of just 11.5 cents per record. More challenging still, individuals are rarely in a position to benefit from the emerging market for health data in any meaningful way. The Evolution of the Medical Record Historically, the medical record was a tool of practice and pedagogy. In the 19th and 20th centuries, hospitals and teaching institutions developed increasingly sophisticated case files, supporting diagnoses, treatments, and post-mortem reviews. But the paper record had limits: it was static, siloed, and difficult to scale. Its value was largely confined to the provider who created or maintained it. This began to change with the advent of electronic health records (EHRs), especially following the 2009 enactment of the HITECH Act as part of the American Recovery and Reinvestment Act. The federal government allocated billions to incentivize the adoption of EHR systems, explicitly aiming to create a "learning healthcare system" that could generate insights from aggregated clinical data. Digitization brought tremendous promise. Actual medical records, with discrete and detailed clinical data, could now be searched, shared, and studied. Health systems could coordinate care more effectively. Researchers could analyze trends across populations. And during the COVID-19 pandemic, the ability to report and track public health data in real time became critically important. But digitization also created new opportunities—and incentives—for data monetization. Who Buys Health Data, and Why? Health data is now big business, with most estimates pegging the market between $2B and $8B. And for good reason: the ability for researchers to investigate vast de-identified digitized datasets to understand how both individuals and therapies behave and respond in the real world (known as Real World Data or RWD), versus the rigid confines of clinical trials, holds the promise of increasing the pace and lowering the cost of medical discovery. In many ways, de-identified health data is nothing new: researchers and others have had access to some data for decades, thanks to medical claims data created by billing and reimbursement between providers and health plans. Claims data, however, can be thought of as a mile wide, an inch deep: it can tell the journey of patients, but isn't sharp on the details. What is new, then, is the depth and robustness of health records themselves: clinical notes, lab values, procedures, outcomes, etc. Pharmaceutical companies now buy RWD to identify candidates for clinical trials and assess treatment effectiveness. Health insurers analyze it to manage costs and stratify patient risk. Startups and AI firms use it to train algorithms, while public health agencies rely on it to monitor disease patterns. Despite these widespread uses, there's still little transparency around what health records are actually worth. That question is further complicated by ethical and legal considerations, which shape not only the price of data but who gets to profit from it. The Ethics and Regulation of Health Data Sharing A recent glaring example of the public's unease with health data and big tech is the story of Project Nightingale. In 2019, Google and Ascension Health launched a partnership to analyze millions of patient records. Both organizations acted within legal boundaries: HIPAA allows patient data sharing for treatment, payment, and healthcare operations purposes. Nonetheless, a whistleblower raised concerns, and public backlash was swift. Critics argued that the scale of the data sharing and the lack of transparency violated patient trust. Healthcare data can be used for other purposes (including research, analytics and/or commercial purposes), but must first be deidentified. The process of deidentification, defined by HIPAA, requires the removal of 18 types of identifiers or an expert determination that the risk of reidentification is very low. But deidentification isn't foolproof, especially with advanced re-identification techniques. And even when the rules are followed, public sentiment may differ from regulatory interpretations. The Project Nightingale controversy illustrates a central tension: legal permissibility does not always equate to ethical acceptability. As data sharing scales and becomes more commercialized, that distinction becomes increasingly salient. What Does The Data Say About The Value Of Health Data? So what is the value of a medical record? According to conversations with several industry experts, the answer depends on several factors. And for people interested in the value of their own health data, it may be disappointing. In general, records of healthy individuals or those with common, well-managed conditions tend to be worth very little. Their data is often less useful for clinical research, predictive modeling, or training AI models. On the other hand, records associated with specific diseases, especially rare or complex conditions, can command far higher value. This is particularly true when the data includes structured lab results, imaging, medication histories, and genomic information. For example, primary care records may be valued as low as 50 cents per patient. Medical imaging data (from MRIs, CT scans, ultrasounds or X-rays) may be worth $30, depending on the underlying medical condition, purpose and location of the scan. In contrast, oncology medical records can be worth between $950 and $2,000 per patient, and genomic data alone can command $1,700 to $5,000. When genomic data is linked with phenotypic data, a combination prized by precision medicine companies, the value can exceed $6,000. Also worth noting is that these figures tend to represent value, not prices. Value in this context refers to the revenue a record holder can generate over time from selling data to multiple customers, rather than the price they might get from an individual buyer. For instance, while Tempus AI, a genomic lab company, realized an average of $1,899 in revenue per de-identified record, this was over a five year time horizon. Further data from Tempus suggests that health data may be subject to normal economic laws: as supply increases, prices may come down. Its revenue generated per record for new patients has decreased over successive years, from $502 per record in 2019 to $128 per record in 2023 (based on the author's firm's analysis). Further, the price a data broker or pharmaceutical company is willing to pay varies depending on the specific use case they are focused on, the supply and availability of similar data, and the ease of acquisition. Why It's Not Easy To Cash In There are several reasons why individual Americans can't easily profit from the value of their health data. First, while federal law (via HIPAA) guarantees a right of access to one's medical records, most patients do not have a comprehensive or consolidated copy. Health data is often fragmented across hospitals, clinics, pharmacies, labs, and insurers. Second, even with digital access, which most providers are now enabled (and effectively mandated) to make available, individual patients lack the market power or technical means to sell their data. The demand side of the data economy (e.g., pharmaceutical companies) generally needs hundreds or thousands (or more) records to suit their research purposes. Aggregated datasets are more valuable and easier to use than individual records. As a result, natural aggregators like hospitals, health systems, and EHR vendors are better positioned to meet that demand. Third, most individuals lack the necessary tools to de-identify their data or license it for specific purposes. While some technology companies are attempting to create platforms for personal data monetization, these remain nascent and face significant adoption and regulatory hurdles. There are companies out there seeking to change this paradigm. San Francisco-based Evidation Health has raised hundreds of millions of dollars to create a technology platform to help consumers aggregate their health and wellness data and enable them to participate in sponsored research. 'Individuals' data has value, and we believe they should share in that value,' notes Evidation's CEO Leslie Oley Wilberforce. Despite Evidation's progress - the company raised more capital in 2024 to accelerate growth - consumer awareness and adoption of these types of platforms remains nascent. The result is a market that extracts value from consumers without empowering them to participate. Americans may believe their data is worth hundreds of dollars, but without access, infrastructure, or market presence, they remain on the outside looking in. Case Study: 23andMe Perhaps no example better encapsulates the promise and peril of consumer health data than 23andMe. Once a darling of the direct-to-consumer genomics boom, the company amassed genetic data from more than 15 million people. It offered inexpensive at-home DNA tests, promising ancestry insights and health risk predictions. But the real business model was always data. 23andMe struck multiple deals with pharmaceutical companies, including a major collaboration with GlaxoSmithKline. These agreements were designed to monetize its enormous trove of genomic and phenotypic data for drug discovery and clinical research. Yet by 2025, the company had filed for Chapter 11 bankruptcy. Just weeks later, it was acquired by Regeneron for a mere $256 million—a dramatic fall from its $6 billion valuation just a few years prior. The decline was accelerated by a 2023 data breach affecting 6.9 million users, and growing public unease over privacy practices. The 23andMe story is a cautionary tale. Consumers willingly handed over their most intimate biological data, only to see that data become an asset in corporate transactions they had no control over. Even if Regeneron maintains 23andMe's stated privacy policies, the legal and ethical framework governing genetic data in the U.S. remains weak and fragmented. Conclusion: A Market With Limited Participation We began this story on papyrus scrolls, when medical records served the care of a single person and had little value beyond their immediate use. Today, we live in an age where those records are digitized, replicated, analyzed, and sold, often without the knowledge or benefit of the people to whom they pertain. So what is your health data worth? The disappointing answer is: it depends, but don't quit your day job, because you likely can't capitalize on it yet anyway. As the health data economy matures, we must grapple with fundamental questions: Who benefits? Who decides how data is used? And how can patients be treated not just as data points, but as participants in a system built on their personal information? In the next article in this series, we'll explore how health data is actually priced: who pays what, for which kinds of data, and what that tells us about the real value of your medical record.
